PL179215B1 - sposób wytwarzania wyciagu i srodek farmaceutyczny PL PL PL PL PL PL PL PL - Google Patents

sposób wytwarzania wyciagu i srodek farmaceutyczny PL PL PL PL PL PL PL PL

Info

Publication number
PL179215B1
PL179215B1 PL94307088A PL30708894A PL179215B1 PL 179215 B1 PL179215 B1 PL 179215B1 PL 94307088 A PL94307088 A PL 94307088A PL 30708894 A PL30708894 A PL 30708894A PL 179215 B1 PL179215 B1 PL 179215B1
Authority
PL
Poland
Prior art keywords
thrombin
polypeptide
glu
pro
leeches
Prior art date
Application number
PL94307088A
Other languages
English (en)
Polish (pl)
Other versions
PL307088A1 (en
Inventor
Juergen Hemberger
Roy Sawyer
Sabine Wolf
Johannes Dodt
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL307088A1 publication Critical patent/PL307088A1/xx
Publication of PL179215B1 publication Critical patent/PL179215B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL94307088A 1993-05-07 1994-05-03 sposób wytwarzania wyciagu i srodek farmaceutyczny PL PL PL PL PL PL PL PL PL179215B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309509A GB9309509D0 (en) 1993-05-07 1993-05-07 Thrombin inhibitors
PCT/EP1994/001404 WO1994026777A1 (en) 1993-05-07 1994-05-03 Thrombin inhibitors

Publications (2)

Publication Number Publication Date
PL307088A1 PL307088A1 (en) 1995-05-02
PL179215B1 true PL179215B1 (pl) 2000-08-31

Family

ID=10735154

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94307088A PL179215B1 (pl) 1993-05-07 1994-05-03 sposób wytwarzania wyciagu i srodek farmaceutyczny PL PL PL PL PL PL PL PL

Country Status (22)

Country Link
US (1) US5583111A (da)
EP (1) EP0652900B1 (da)
JP (1) JP3537437B2 (da)
KR (1) KR100335536B1 (da)
AT (1) ATE208793T1 (da)
AU (1) AU682368B2 (da)
CA (1) CA2139652C (da)
CZ (1) CZ287794B6 (da)
DE (1) DE69429062T2 (da)
DK (1) DK0652900T3 (da)
ES (1) ES2167364T3 (da)
GB (1) GB9309509D0 (da)
HU (1) HU226243B1 (da)
NO (1) NO318017B1 (da)
PL (1) PL179215B1 (da)
PT (1) PT652900E (da)
RU (1) RU2138275C1 (da)
SK (1) SK282860B6 (da)
TW (1) TW369541B (da)
UA (1) UA43831C2 (da)
WO (1) WO1994026777A1 (da)
ZA (1) ZA943171B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783087B2 (en) * 1999-08-06 2005-09-22 Genentech Inc. Peptide antagonists of factor VIIA
GB9930659D0 (en) * 1999-12-24 2000-02-16 Bio Discovery Ltd Inhibitors of complement activation
FR2834293B1 (fr) * 2002-01-03 2005-02-04 Ricarimpex Extraits de sangsues a effet psychosomatique
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
EP1931733A4 (en) 2005-09-28 2009-11-25 Biovascular Inc METHOD AND COMPOSITIONS FOR BLOCKING THROMBOZYTE AND CELL ADHESION, CELL MIGRATION AND IGNITION
CN101095697A (zh) * 2006-06-28 2008-01-02 李振国 水蛭和/或地龙分子量5800道尔顿以下的提取物
TWI471321B (zh) * 2009-06-08 2015-02-01 Abbott Gmbh & Co Kg Bcl-2族群抑制劑之口服醫藥劑型
RU2519741C2 (ru) * 2012-06-25 2014-06-20 Общество с ограниченной ответственностью Научно-внедренческая фирма "Гируд И.Н." (ООО НВФ "Гируд И.Н.") Фармацевтическая композиция, обладающая противотромботическим, тромболитическим, иммуномодулирующим, противовоспалительным действиями, нормализующая липидный и углеводный обмен
US8790711B2 (en) 2012-09-17 2014-07-29 Biopep Solutions, Inc. Treating diabetes with a whole, leech saliva extract
CN108395475B (zh) * 2018-03-29 2021-09-10 苏州至汇生物科技有限公司 一种基于亲和层析的水蛭素分离纯化方法
CN116987181B (zh) * 2023-09-27 2023-12-08 北京元延医药科技股份有限公司 高生物学活性的天然水蛭素和高收率制备它们的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
GB8826428D0 (en) * 1988-11-11 1988-12-14 Biopharm Ltd Antithrombin
DE69127346T2 (de) * 1990-04-06 1998-02-26 Merck Patent Gmbh, 64293 Darmstadt Behandlung thrombotischer ereignisse

Also Published As

Publication number Publication date
HU9500038D0 (en) 1995-03-28
US5583111A (en) 1996-12-10
HU226243B1 (en) 2008-07-28
SK282860B6 (sk) 2002-12-03
RU95105983A (ru) 1997-02-27
PT652900E (pt) 2002-05-31
DE69429062T2 (de) 2002-06-20
PL307088A1 (en) 1995-05-02
DE69429062D1 (de) 2001-12-20
UA43831C2 (uk) 2002-01-15
NO318017B1 (no) 2005-01-24
AU682368B2 (en) 1997-10-02
DK0652900T3 (da) 2002-02-25
CZ4295A3 (en) 1995-10-18
KR100335536B1 (ko) 2002-11-11
EP0652900B1 (en) 2001-11-14
RU2138275C1 (ru) 1999-09-27
WO1994026777A1 (en) 1994-11-24
GB9309509D0 (en) 1993-06-23
ZA943171B (en) 1995-01-11
CA2139652C (en) 2003-03-18
ATE208793T1 (de) 2001-11-15
HUT70215A (en) 1995-09-28
AU6795094A (en) 1994-12-12
TW369541B (en) 1999-09-11
JPH07508765A (ja) 1995-09-28
CZ287794B6 (en) 2001-02-14
NO950075D0 (no) 1995-01-06
JP3537437B2 (ja) 2004-06-14
SK895A3 (en) 1995-05-10
ES2167364T3 (es) 2002-05-16
EP0652900A1 (en) 1995-05-17
CA2139652A1 (en) 1994-11-24
KR950702579A (ko) 1995-07-29
NO950075L (no) 1995-01-06

Similar Documents

Publication Publication Date Title
Wesselschmidt et al. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa
EP0815139B1 (en) Thrombin inhibitors based on the amino acid sequence of hirudin
JP3811186B2 (ja) 線虫から抽出されるセリンプロテアーゼ阻害剤および抗凝固性タンパク質
MAURER‐FOGY et al. Cloning and expression of cDNA for human vascular anticoagulant, a Ca2+‐dependent phospholipid‐binding protein
US20090137779A1 (en) Peptide inhibitors of thrombin as potent anticoagulants
JPH05508150A (ja) 酸化抵抗性トロンボモジュリン類縁体
Salzet Leech thrombin inhibitors
PL179215B1 (pl) sposób wytwarzania wyciagu i srodek farmaceutyczny PL PL PL PL PL PL PL PL
US5472942A (en) Anti-thrombins
JP2004527452A (ja) 医薬用途のためのトロンボモジュリン
WO1993003748A1 (en) Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
US5955294A (en) Nematode-extracted serine protease inhibitors and anticoagulant proteins
EP0239644A1 (en) Novel physiologically active substance having blood coagulation controlling activity
US5523287A (en) Thrombin-inhibitory protein from assassin bugs
US6841534B2 (en) Protein Z-dependent protease inhibitor
JPH05500906A (ja) 血栓性疾患の治療
DiMaio et al. Thrombin inhibitors and thrombin receptor agonists/antagonists

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20110503